A randomised trial of differentiated prednisolone treatment in active rheumatoid arthritis. Clinical benefits and skeletal side effects

Annals of the Rheumatic Diseases

Volumn 58, Issue 11, 1999, Pages 713-718

  Hansen, Michael ^b   Pødenphant, Jan ^a   Florescu, Adrian ^b   Stoltenberg, Michael ^b   Borch, Alice ^b   Kluger, Elga ^b   Sørensen, Søren Freiesleben ^b   Hansen, Troels Mørk ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; PREDNISOLONE;

ARTICLE; BONE ATROPHY; BONE DENSITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; DRUG EFFECT; HAND RADIOGRAPHY; HUMAN; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS;

EID: 0032722288     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.58.11.713     Document Type: Article

References (14)

1. Salaffi F, Ferraccioli G, Peroni M, Carotti M, Bartoli E, Cervini C.Progression of erosion and joint space narrowing scores in rheumatoid arthritis assessed by nonlinear models. J Rheumatol 1994;21:1626-30.
2. Kirwan JR. The effect of glucocorticosteroids on bone destruction in rheumatoid arthritis. N Engl J Med 1995;333:142-6.
3. Hall GM, Spector TD, Griffin AJ, Jawad ASM, Hall ML, Dovle DV. The effect of rheumatoid arthritis and steroid therapy on bone density in postmenopausal women. Arthritis Rheum 1993;36:1510-16.
4. Gough AKS, Lilley J, Eyre S, Holder RL, Emery P. Generalised bone loss in patients with early reumatoid arthritis. Lancet 1994;344:23-7.
5. Hansen M, Florescu A, Stoltenberg M, Podenphant J, Pedersen-Zbinden B, Horslev-Petersen K, et al. Bone loss in rheumatoid arthritis. Scand J Rheumatol 1996;23:367-76.
6. Arnett FC, Edsworthy SM, Bloch DA, McShane D, Fríes JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.Arthritis Rheum 1988;31:315-24.
7. Fries JF, Spitz PW, Young DY. The dimensions of health outcomes. The health assessment questionaire, disability and pain scales. J Rheumatol 1982;9: 789-93.
8. Larsen A, Dale K, Eek M. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diag 1977;18:181-91.
9. Lilley J, Walters BG, Heath DA, Drole Z. In vivo and in vitro precision for bone density measured by dual energy x-ray absorption. Osteoporosis Int 1991;1:41-6.
10. Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Kluger E, et al. American College of Rheumatology preliminary definitions of improvement in rheumatoid arthritis. Arthritis Rheum 1995;38:727-35.
11. Boers M, Verhoeven AC, Murkusse HM, van de Laar MAFJ, Westhoevens R, et al. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet 1997;350:309-18.
12. Laan RFJM, van Riel PLCM, van de Putte LBA, van Erning LJTH O, van't Hof MA, Lemmers AM. Low-dose prednisolone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. Ann Intern Med 1993;10:963-8.
13. Report by the joint committee of the Medical Research Council and Nuffield Foundation on clinical trials of cortisone, ACTH, and other therapeutic measures in chronic rheumatic diseases. A comparison of prednisolone with aspirin or other analgesics in the treatment of rheumatoid arthritis. Ann Rheum Dis 1959;18:173-88.
14. A second report by the joint committee of the Medical Research Council and Nuffield Foundation on clinical trials of cortisone, ACTH, and other therapeutic measures in chronic rheumatic diseases. A comparison of prednisolone with aspirin or other analgesics in the treatment of rheumatoid arthritis. Ann Rheum Dis 1960;19:331-7.